Share

    


Home / Search Results

Search Results

You searched for:

March is Multiple Myeloma Awareness Month. Learn more about the work ACCC is doing to support oncology professionals in treating patients with this disease.
The first post in ACCC's "Subspeciality Immuno-Oncology Insights" series—the APP perspective and real-world strategies for tackling current challenges in the delivery of immunotherapies for cancer.
With the treatment of chronic lymphocytic leukemia (CLL) shifting substantially in the last five years, learn how ACCC is supporting oncology professionals in integrating oral oncolytics in CLL practice.
ACCCBuzz spoke with Dr. Dan Vogl to learn more about the treatment options available to patients with multiple myeloma, including the benefits of adding anti-CD38 monoclonal antibodies in either first- or second-line treatment.
Patients receiving anti-cancer infusions often experience lengthy appointment wait times due to the highly complex nature of their care. To address this lack in communication, Vanderbilt-Ingram Cancer Center developed a digital wallboard to better inform patients of their appointment status.
ACCC has launched Transforming Complex to Clear—a precision medicine campaign that has developed a range of tools and resources to help bring clarity to complex patient care decisions. Designed for multidisciplinary cancer teams, learn more about how these resources can enable clinicians to make educated and confident decisions.
With total spending on U.S. cancer care projected to rise 34 percent from 2015-2030 to $245 billion, biosimilars can play a role in helping reduce those costs. Learn how Biden’s executive order on promoting competition in the American economy will require the FDA's biosimilars approval framework to be clearer and easier to follow.